Molecular and functional investigation of the role of HLA-F in immune regulation

HLA-F在免疫调节中作用的分子和功能研究

基本信息

  • 批准号:
    10636894
  • 负责人:
  • 金额:
    $ 66.7万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-06-06 至 2027-05-31
  • 项目状态:
    未结题

项目摘要

Project Summary/Abstract HLA-F is a nonclassical class I MHC (Ib) molecule that has been found expressed on a variety of cancers, shown to play a role in HIV and adenoviral infection, the neurological autoimmune disease ALS and is expressed throughout pregnancy. Despite the potential importance of this protein in these conditions, little is known about this molecule in terms of its function or even in which conformational state it is expressed. We have recently shown that, in addition to being expressed as a heavy chain only state, or open conformer (HLA-FOC), HLA-F can also be expressed as a bon fide peptide presenting molecule, associated with the β2m subunit (pHLA-F). Peptides are presented in an unconventional way, with the N-terminus not anchored within the groove and the potential for post-translational modifications featuring in peptide anchoring. Despite these advances, there remains much unknown about how these conformer states are regulated, how it engages its various receptors in each of these conformer states, and the role of HLA-F in its various environments of tumor surveillance, autoimmunity and reproduction. Thus, the aims of this proposal focus on addressing these questions and are: Aim 1: To investigate, structurally and functionally, the various conformer states that HLA-F adopts in human health and disease. We will pursue structural studies of the HLA-F isoforms to understand how these two states differ from each other. Using conformer-specific antibodies, we will determine what cell types express which (or both) forms and how this differs between healthy and disease cells. We will also pursue peptide elution studies from a range of human sources to determine if the peptide repertoire shifts depending on cellular origin or disease. Aim 2: To identify and analyze the factors that regulate the production or interchange of HLA- F conformers and splice forms in a cell. We will explore the cellular factors that may play a role in switching HLA-F between peptide-loaded and HLA-FOC as well as an intriguing splice variant of HLA-F of unknown function. Finally, in Aim 3 we seek to establish the receptor repertoire that engage HLA-F in its various conformer states, determine the molecular basis for their association and study the functional consequences of their binding. We will employ the structural, biophysical and functional expertise of the Adams lab to determine the receptor repertoire that engage these conformer states of HLA-F and study them at the functional and molecular level.
项目总结/摘要 HLA-F是一种非经典的I类MHC(Ib)分子,已发现其在多种癌症上表达, 显示在HIV和腺病毒感染、神经系统自身免疫性疾病ALS中发挥作用, 整个怀孕期间。尽管这种蛋白质在这些条件下的潜在重要性,但人们对它知之甚少。 这个分子在它的功能方面,甚至在它表达的构象状态。我们最近 显示,除了表达为仅重链状态或开放构象(HLA-FOC)之外,HLA-F 也可以表达为与β 2 m亚基(pHLA-F)相关的真正的肽呈递分子。 肽以非常规的方式呈现,其中N-末端不锚定在沟内,并且N-末端不锚定在沟内。 潜在的翻译后修饰特征在于肽锚定。尽管有这些进步, 这些构象状态是如何被调节的,它是如何与各种受体结合的, 在这些构象状态中的每一种,以及HLA-F在其各种肿瘤监视环境中的作用, 自身免疫和生殖因此,本提案的目的是着重解决这些问题,即: 目的1:从结构和功能上研究HLA-F在HLA-F中所采用的各种构象状态, 人类健康和疾病。我们将继续进行HLA-F同种型的结构研究,以了解这些基因是如何被激活的。 两种状态彼此不同。使用符合者特异性抗体,我们将确定哪些细胞类型表达 这两种形式以及健康细胞和疾病细胞之间的差异。我们还将进行肽洗脱 从一系列人类来源的研究,以确定肽库是否根据细胞来源发生变化 或者疾病目的2:鉴定和分析调节HLA-1产生或交换的因素。 F构象和剪接形式。我们将探讨可能在转换中发挥作用的细胞因素 HLA-F之间的肽加载和HLA-FOC,以及一个有趣的剪接变体的HLA-F的未知功能。 最后,在目标3中,我们试图建立受体库,使HLA-F在其各种构象异构体中结合, 状态,确定其关联的分子基础,并研究 他们的约束力。我们将利用亚当斯实验室的结构、生物物理和功能专业知识来确定 受体库,从事这些构象状态的HLA-F和研究他们在功能和 分子水平。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Erin June Adams其他文献

Erin June Adams的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Erin June Adams', 18)}}的其他基金

Investigation into the Endogenous Ligand Repertoire of the Non-Classical MHC-Related Protein, MR1 in Multiple Myeloma Cell Lines
多发性骨髓瘤细胞系中非经典 MHC 相关蛋白 MR1 内源配体库的研究
  • 批准号:
    10557884
  • 财政年份:
    2022
  • 资助金额:
    $ 66.7万
  • 项目类别:
Molecular and functional investigation of the role of HLA-F in immune regulation
HLA-F在免疫调节中作用的分子和功能研究
  • 批准号:
    10503676
  • 财政年份:
    2022
  • 资助金额:
    $ 66.7万
  • 项目类别:
Investigation into the Endogenous Ligand Repertoire of the Non-Classical MHC-Related Protein, MR1 in Multiple Myeloma Cell Lines
多发性骨髓瘤细胞系中非经典 MHC 相关蛋白 MR1 内源配体库的研究
  • 批准号:
    10452305
  • 财政年份:
    2022
  • 资助金额:
    $ 66.7万
  • 项目类别:
Determining the Origins of Nonclassical Class I molecules through Molecular and Functional Approaches
通过分子和功能方法确定非经典 I 类分子的起源
  • 批准号:
    10501472
  • 财政年份:
    2022
  • 资助金额:
    $ 66.7万
  • 项目类别:
Determining the Origins of Nonclassical Class I molecules through Molecular and Functional Approaches
通过分子和功能方法确定非经典 I 类分子的起源
  • 批准号:
    10645114
  • 财政年份:
    2022
  • 资助金额:
    $ 66.7万
  • 项目类别:
Facility and Building System Upgrades Support for the Howard T. Ricketts Biocontainment Laboratory
为 Howard T. Ricketts 生物防护实验室提供设施和建筑系统升级支持
  • 批准号:
    10394614
  • 财政年份:
    2021
  • 资助金额:
    $ 66.7万
  • 项目类别:
Facility and Building System Upgrades Support for the Howard T. Ricketts Biocontainment Laboratory
为 Howard T. Ricketts 生物防护实验室提供设施和建筑系统升级支持
  • 批准号:
    10631368
  • 财政年份:
    2021
  • 资助金额:
    $ 66.7万
  • 项目类别:
Molecular and functional investigation of the role of CD1 in gamma delta T cell surveillance
CD1 在 γ δ T 细胞监测中作用的分子和功能研究
  • 批准号:
    10670830
  • 财政年份:
    2020
  • 资助金额:
    $ 66.7万
  • 项目类别:
Molecular and functional investigation of the role of CD1 in gamma delta T cell surveillance
CD1 在 γ δ T 细胞监测中作用的分子和功能研究
  • 批准号:
    10268214
  • 财政年份:
    2020
  • 资助金额:
    $ 66.7万
  • 项目类别:
Molecular and functional investigation of the role of CD1 in gamma delta T cell surveillance
CD1 在 γ δ T 细胞监测中作用的分子和功能研究
  • 批准号:
    10462661
  • 财政年份:
    2020
  • 资助金额:
    $ 66.7万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 66.7万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 66.7万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 66.7万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 66.7万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 66.7万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 66.7万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 66.7万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 66.7万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 66.7万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 66.7万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了